Wave Life Sciences, Inc.
WVEFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Wave Life Sciences, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 13 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Mar 30, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| ADAR1 Capital Management, LLC | 2026-03-31 | 44,900 | $326K | SEC filing |
| Qube Research & Technologies Ltd | 2026-03-31 | 155,924 | $1.13M | SEC filing |
| Hudson Bay Capital Management LP | 2026-03-31 | 6,200 | $45K | SEC filing |
| Entropy Technologies, LP | 2026-03-31 | 28,348 | $206K | SEC filing |
| Handelsbanken Fonder AB | 2026-03-31 | 65,500 | Not shown | SEC filing |
| PNC FINANCIAL SERVICES GROUP, INC. | 2026-03-31 | 27 | $196 | SEC filing |
| Creative Planning | 2026-03-31 | 27,574 | $200K | SEC filing |
| NOMURA ASSET MANAGEMENT CO LTD | 2026-03-31 | 0 | $0 | SEC filing |
| Virtu Financial LLC | 2026-03-31 | 76,779 | Not shown | SEC filing |
| Kemnay Advisory Services Inc. | 2026-03-31 | 1,201 | $8.71K | SEC filing |
| HRT FINANCIAL LP | 2026-03-31 | 321,376 | Not shown | SEC filing |
| Private Advisor Group, LLC | 2026-03-31 | 22,100 | $160K | SEC filing |
| LPL Financial LLC | 2026-03-31 | 10,373 | $75.2K | SEC filing |
| Caption Management, LLC | 2026-03-31 | 43,200 | $313K | SEC filing |
| Scientech Research LLC | 2026-03-31 | 200,331 | $1.45M | SEC filing |
| EMERALD ADVISERS, LLC | 2026-03-31 | 1,261,183 | $9.14M | SEC filing |
| RENAISSANCE TECHNOLOGIES LLC | 2026-03-31 | 597,220 | $4.33M | SEC filing |
| Nuveen, LLC | 2026-03-31 | 657,720 | $4.77M | SEC filing |
| Invesco Ltd. | 2026-03-31 | 199,740 | $1.45M | SEC filing |
| True Wealth Design, LLC | 2026-03-31 | 42 | $305 | SEC filing |
- Each value is checked against Wave Life Sciences, Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 3 rows: the filed value is about 1,000 times too small for the share count at Wave Life Sciences, Inc.'s share price.
120 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Wave Life Sciences, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2025-12-08 · Moran Kyle: Larger than 69 of the 76 other insider sales of Ordinary Shares on file. SEC filing
- 2025-12-08 · Francis Chris: Larger than 74 of the 76 other insider sales of Ordinary Shares on file. SEC filing
- 2025-12-08 · Francis Chris: Larger than 73 of the 76 other insider sales of Ordinary Shares on file. SEC filing
- 2025-08-22 · BOLNO PAUL: Larger than all 76 other insider sales of Ordinary Shares on file. SEC filing
- 2025-03-07 · BOLNO PAUL: Larger than 75 of the 76 other insider sales of Ordinary Shares on file. SEC filing
- 2024-10-16 · BOLNO PAUL: Larger than 72 of the 76 other insider sales of Ordinary Shares on file. SEC filing
- 2024-10-16 · Francis Chris: Larger than 70 of the 76 other insider sales of Ordinary Shares on file. SEC filing
- 2024-10-16 · Francis Chris: Larger than 71 of the 76 other insider sales of Ordinary Shares on file. SEC filing
- 2022-06-16 · RA Capital Healthcare Fund LP: Larger than all 8 other insider purchases of Ordinary Shares on file. SEC filing
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-03-30 | RA Capital Healthcare Fund LP · Director, 10% owner | Ordinary Shares | P — Open market or private purchase | +971,091 | 6.50 | SEC filing |
| 2026-03-27 | RA Capital Healthcare Fund LP · Director, 10% owner | Ordinary Shares | P — Open market or private purchase | +2,495,623 | 6.43 | SEC filing |
| 2026-03-26 | RA Capital Healthcare Fund LP · Director, 10% owner | Ordinary Shares | P — Open market or private purchase | +351,224 | 6.38 | SEC filing |
| 2026-03-26 | RA Capital Healthcare Fund LP · Director, 10% owner | Ordinary Shares | P — Open market or private purchase | +4,954,558 | 6.06 | SEC filing |
| 2026-02-26 | Francis Chris · See Remarks | Ordinary Shares | S — Open market or private sale | −17,900 | 15.09 | SEC filing |
| 2026-02-26 | Francis Chris · See Remarks | Ordinary Shares | S — Open market or private sale | −15,294 | 15.00 | SEC filing |
| 2026-02-09 | Moran Kyle · Chief Financial Officer | Ordinary Shares | S — Open market or private sale | −3,588 | 13.45 | SEC filing |
| 2026-02-09 | Francis Chris · See Remarks | Ordinary Shares | S — Open market or private sale | −1,883 | 13.45 | SEC filing |
Showing 8 of 20 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-03-23 | TAKANASHI KEN · Director | Ordinary Shares | C — Conversion of derivative security | +3,901,348 | SEC filing |
| 2026-03-23 | TAKANASHI KEN · Director | Series A Preferred Shares | C — Conversion of derivative security | −3,901,348 | SEC filing |
| 2026-02-26 | Francis Chris · See Remarks | Share Option (right to buy) | M — Exercise or conversion of derivative security | −17,900 | SEC filing |
| 2026-02-26 | Francis Chris · See Remarks | Ordinary Shares | M — Exercise or conversion of derivative security | +15,294 | SEC filing |
| 2026-02-26 | Francis Chris · See Remarks | Share Option (right to buy) | M — Exercise or conversion of derivative security | −15,294 | SEC filing |
| 2026-02-26 | Francis Chris · See Remarks | Ordinary Shares | M — Exercise or conversion of derivative security | +17,900 | SEC filing |
| 2026-02-05 | Moran Kyle · Chief Financial Officer | Ordinary Shares | A — Grant, award, or other acquisition | +45,625 | SEC filing |
| 2026-02-05 | BOLNO PAUL · President and CEO | Share Option (right to buy) | A — Grant, award, or other acquisition | +1,000,000 | SEC filing |
Showing 8 of 20 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.